Clinical Trial Update: Ethosomal Gel Bearing Losartan 5% for Keloid Treatment [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for an ethosomal gel containing losartan 5% being tested for keloid treatment (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Losartan 5% Ethosomal Gel (losartan)

Snippet

Sponsor: Yuni Eka Anggraini | Conditions: Keloid | Phase 1, Phase 2 | Status: UNKNOWN